Alzheimer s Disease Pipeline Review H1

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Respiratory Therapy News FEBRUARY 2015

Respiratory Therapy News FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 13 pages

Industry Trend Analysis - AstraZeneca Further Bolsters Respiratory Portfolio Industry Trend Analysis - IPF ODD Status Advances PBI-4050 Toward Success Industry Brief - GSK Launches Two Products In US For Asthma/COPD Industry Brief - CHMP Adopts Positive Opinion On Abraxane For First-Line NSCLC Industry ...

Industries: Therapy | Countries: World, United States

Acorda Therapeutics, Inc., Wright Investors' Service

Acorda Therapeutics, Inc., Wright Investors' Service

  • $ 55
  • Company report
  • by Wright Investors' Service
  • February 2015
  • 56 pages

A textual analysis of the financial results for Acorda Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy | Countries: United States

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015  - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

  • $ 3 500
  • Industry report
  • by Kelly Scientific Publications
  • February 2015
  • 254 pages

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 270 tables & figures over 254 pages. The personalized medicine (global) market is presented as follows: • By ...

Industries: Therapy | Countries: Europe, World, France, Germany, United Kingdom, United States, Spain, Italy

Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • February 2015
  • 56 pages

A textual analysis of the financial results for Pluristem Therapeutics Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy | Countries: Israel, United States

Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • by Delve Insight
  • February 2015
  • 100 pages

DelveInsight's, “Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Acute Pain. A key objective of DelveInsight's report is to establish the understanding for API Manufacturers ...

Industries: Therapy | Countries: United States

Allergic Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Allergic Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • by Delve Insight
  • February 2015
  • 100 pages

DelveInsight's, “Allergic Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Allergic Conjunctivitis. A key objective of DelveInsight's report is to establish the ...

Industries: Therapy | Countries: United States

Cancer Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Cancer Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • by Delve Insight
  • February 2015
  • 100 pages

DelveInsight's, “Cancer Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Cancer Pain. A key objective of DelveInsight's report is to establish the understanding for API ...

Industries: Therapy | Countries: United States

Chemotherapy Induced Nausea and Vomiting-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Chemotherapy Induced Nausea and Vomiting-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • by Delve Insight
  • February 2015
  • 100 pages

DelveInsight's, “Chemotherapy Induced Nausea and Vomiting-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Chemotherapy Induced Nausea and Vomiting. A key objective of DelveInsight's ...

Industries: Therapy | Countries: United States

Chronic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Chronic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • by Delve Insight
  • February 2015
  • 100 pages

DelveInsight's, “Chronic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Chronic Pain. A key objective of DelveInsight's report is to establish the understanding for API ...

Industries: Therapy | Countries: United States

Dental Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Dental Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • by Delve Insight
  • February 2015
  • 100 pages

DelveInsight's, “Dental Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Dental Pain. A key objective of DelveInsight's report is to establish the understanding for API ...

Industries: Therapy | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.